Ger van Jeveren founded Fagron, a pharmaceutical company, which is nowadays stock quoted at the Euronext. He currently is Investor Committee member of Newport Capital and served as Member of the Board of Directors at Omega Pharma, Arseus Medical and Arseus Dental. Moreover, Ger had more than 100 companies acquired and/or developed and was also involved in numerous start-ups such as Arseus Dental and a sterile production facility in the US. Ger has a good pharma MedTech network in the US and Europe. His expertise lies in product development, marketing and sales and validation of manufacturing processes.